Assess arm endurance measurement reliability
- Trial ID
- NCT06482502
- Official Title
- Investigation of the Validity and Reliability of the 6-Minute Pegboard and Ring Test in Parkinson's Patients for Upper Extremity Endurance Assessments
- Goal
- Assess arm endurance measurement reliability
- Status
- RECRUITING
- Sponsor
- Emre Şenocak
- Study Type
- OBSERVATIONAL
- Enrollment
- 34 participants
- Conditions
- Parkinson Disease
Plain-Language Summary
The goal is to see whether a simple six minute pegboard and ring test gives valid, repeatable measures of arm endurance in people with Parkinson's. Participants move rings between pegs for six minutes while researchers check how consistent and accurate the results are, this is an observational assessment rather than a treatment so it does not change or interact with medications like levodopa. They are enrolling people aged 45 to 75 with mild to moderate Parkinson's (Hoehn and Yahr stage 3 or lower), who have full shoulder motion, no recent intensive rehab, and no severe heart disease, upper limb orthopedic problems, other neurological diagnoses, uncorrected vision or significant cognitive impairment, and no recent medication changes.
Locations
- İstanbul Medilife Beylikdüzü Hospital, Istanbul, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. The goal is to see whether a simple six minute pegboard and ring test gives valid, repeatable measures of arm endurance in people with Parkinson's. Participants move rings between pegs for six minutes while researchers check how consistent and accurate the results are, this is an observational assessment rather than a treatment so it does not change or interact with medications like levodopa. They are enrolling people aged 45 to 75 with mild to moderate Parkinson's (Hoehn and Yahr stage 3 or lower), who have full shoulder motion, no recent intensive rehab, and no severe heart disease, upper limb orthopedic problems, other neurological diagnoses, uncorrected vision or significant cognitive impairment, and no recent medication changes.
- Who can participate?
- Participants must be between 45 Years and 75 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.